40
Key Proteo raises $2.33M in biotech capital round under Reg D 506(b)
Company raise · Raising · SEATTLE, WA · Form D filed 2026-10-23
Key Proteo, a Delaware biotech corporation based in Seattle, has raised $2.33M of a $2.5M offering under Regulation D 506(b) exemption. The company closed its first sale in March 2026 and has attracted three investors to date.
other
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| SIHOUN HAHN | Executive Officer, Director, Promoter |
| JAE-HOON SONG | Director |
| KOO JA-KYUM | Director |
Signed by Sihoun Hahn, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.